Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kechuanning Tablets (also known as Tongzhi Kechuanning Tablets) is a traditional Chinese medicine (TCM) developed and manufactured by Wuhan United Pharmacy. It is formulated as an oral film-coated tablet containing a mixture of botanical extracts from Ephedra, Aster tataricus, Stemona, Licorice, and Bitter Apricot Seed. The product is indicated for relieving cough and resolving phlegm, and is clinically used to treat common cold coughs as well as acute and chronic bronchitis. It is approved and marketed in China under the brand name Tongzhi (同治).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kechuanning Tablets (Wuhan United Pharmacy).